#coinfection

Many of the 215 injection-drug-related HIV infections could have been averted from a swifter response, according to researchers’ estimates.

Nevertheless, researchers advise careful kidney monitoring when pairing the medications.

Using opioid medication treatment such as methadone appears to lower this risk.

According to a study of Parisian men who have sex with men, hepatitis C transmission networks include HIV-negative and -positive men.

A major mitigating factor may be treating HIV with antiretrovirals.

Research found that healthcare providers could do better at preventing drug interactions.

A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)

One percent of gay and bi men in a Dutch PrEP study contracted hepatitis C annually; of those cured, one in four were reinfected per year.

Among a group of largely HIV-positive gay and bi men, Zepatier (grazoprevir/elbasvir) boasted a 99 percent cure rate.

A study comparing on-demand and daily PrEP has seen lower side effects with daily use and an overall trend of increased sexual risk-taking.

Scott County, Indiana, recently saw a major outbreak of HIV and hepatitis C among people who inject drugs.

This is according to an analysis of multiple factors potentially related to a diabetes diagnosis in a large group of French people with HIV.

This was among a small group of people who contracted the virus within one year, most of whom had HIV as well.

People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.

Researchers from a German cohort found that the reinfection rate for men who have sex with men was almost 10 percent per year.

Suppressing HIV with antiretrovirals shortens the acute hepatitis A virus disease course.